DoseCraft
VapeHeatLab
GG #4 05262022 L1 Test Sample
About
GG #4 05262022 L1 Test Sample is a hybrid cannabis strain. Lab samples test between 16.2% and 21.9% THC, with caryophyllene (0.37%) as the dominant terpene.
Why does GG #4 05262022 L1 Test Sample feel pain-relieving?
GG #4 05262022 L1 Test Sample's pain-relieving effects are linked to its dominant caryophyllene (0.37%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by limonene (0.17%), known for mood elevation and stress relief.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 16.2–21.9%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout GG #4 05262022 L1 Test Sample
- GG #4 05262022 L1 Test Sample is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- GG #4 05262022 L1 Test Sample typically tests at 16.2% to 21.9% THC.
- The dominant terpenes in GG #4 05262022 L1 Test Sample are Caryophyllene, Limonene, Myrcene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.